Anthrax immune globulin
From WikiMD's WELLNESSPEDIA
Anthrax immune globulin, tradename Anthrasil, is a human immune globulin that is used in combination with antibiotics to treat anthrax. It was developed by Cangene and purchased in 2011 by the Biomedical Advanced Research and Development Authority (BARDA) under Project Bioshield. On 24 March 2015 it was granted approval by the United States Food and drug Administration for use in treating inhalation anthrax in conjunction with antibiotics.
| This article is a stub. You can help WikiMD by registering to expand it. |
